"same time" as in within a few days, not 12-18 month later. I was aware that patients aren't being operated on at the exact same time as they are being injected. It should be obvious that there's no point of biopsying a patient an extended period after imaging?
Love your research, but not sure what's achieved by this type of nit-picking rather than addressing the point that's being made?
As you noted, the company planned on completing the trial in Feb-25. Its now saying that it plans on submitting diagnostic approvals that emanate from CLARIFY and AMPLIFY at the same time and AMPLIFY is for over 200 patients and hasn't started. So CLARIFY taking at least twice as long as planned is not an opinion, its a fact . The company not explicitly announcing this material blowout is also not an opinion. The record price erosion in under six months for a company that entered the ASX200 is also not an opinion.
CU6 Price at posting:
$2.02 Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)